Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

THC Biomed Intl Ltd C.THC

Alternate Symbol(s):  THCBF

THC Biomed Intl Ltd. is a Canada-based cannabis producer. The Company’s principal business is the production and sale of cannabis through THC BioMed Ltd., which is a small batch Licensed Producer as regulated by the Cannabis Act which regulates the production, distribution, and possession of cannabis for both medical and adult recreational access in Canada. The Company’s biological assets consist of cannabis plants (mother plants and clones for growth); resin; oil; harvested marijuana flowers prior to completion of the drying, grading and testing processes; and edible concentrate. The Company operates in a single reportable segment being the cultivation and sale of cannabis. Its subsidiaries include THC BioMed Ltd., Clone Shipper Ltd., THC BioMed Victoria Falls Ltd., THC2GO Dispensaries Ltd. (THC2GO), and THC BioMed Lesotho Ltd. (THC Lesotho). Clone Shipper Ltd. owns all rights to the Clone Shipper product used to transport live plants.


CSE:THC - Post by User

Bullboard Posts
Post by ChefBHTon Mar 19, 2019 4:56pm
86 Views
Post# 29507501

A reply from (a member) of the BOD

A reply from (a member) of the BODInspired by vinny’s proactive approach recently, I reached out to one of the BOD and thought I would share my results below. I remain - LONG and faithful...Go THC!!

Hello.
 
Please understand I cannot offer any investment advice or prospects for investment.
 
Regarding THC Biomed Intl. I have served on that board since the go public date from a few years ago.
 
John Miller is a little press shy but my group was attracted to him (Hee Jun is his wife) as they had secured a license to grow cannabis for research purposes even before the MMAR model and we were confident that they would be able to get licensed in the then evolving model (which proved true).
 
Having residual strains and growing experience proves beneficial  in this complicated regulatory agricultural model and John and Hee Jun have assembled a dedicated team.
 
The model is not massive grow rooms and my personal observation is that massive rooms aren't always the path to successful growing and as quality becomes more and more critical I think the results should remain positive.
 
No doubt there are a few complaints that John doesn't focus resources in IR but on the other hand the team is very cost conscious and driven for profitability. Best (regards).
Bullboard Posts